Dose-relationship of Vaginally Administrated Oxytocin in Postmenopausal Women

PHASE2CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

December 31, 2012

Study Completion Date

January 31, 2013

Conditions
Vaginal Atrophy
Interventions
DRUG

Oxytocin 100 i.u.

DRUG

Oxytocin 400 i.u.

DRUG

Placebo

Trial Locations (1)

14186

Karolinska University Hospital, Stockholm

Sponsors
All Listed Sponsors
collaborator

Pharma Consulting Group AB

INDUSTRY

lead

PepTonic Medical AB

INDUSTRY

NCT01987804 - Dose-relationship of Vaginally Administrated Oxytocin in Postmenopausal Women | Biotech Hunter | Biotech Hunter